BiotechTube
Veloxity Labs

Veloxity Labs

San Diego, United States· Est.
veloxitylabs.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2018, Veloxity Labs is a privately held, revenue-generating CRO that provides specialized LC-MS bioanalytical services to drug developers. The company differentiates itself through its emphasis on rapid turnaround times, claiming to move from sample to decision in days rather than weeks, supported by its proprietary VELO™ system for workflow automation. It operates in a high-growth niche, capitalizing on the increasing demand for peptide analysis (e.g., GLP-1s) and the need for speed in preclinical and clinical development. Veloxity's model is built on serving as an essential, outsourced partner for companies lacking in-house bioanalytical capabilities.

DiagnosticsDigital Health

Technology Platform

Proprietary VELO™ system for automated LC-MS bioanalytical workflows, emphasizing speed and data integrity from sample to report.

Opportunities

High demand for specialized bioanalysis of complex modalities like GLP-1 peptides presents a major growth vertical.
The industry-wide need to accelerate drug development timelines aligns perfectly with the company's core value proposition of speed.
The trend towards outsourcing non-core R&D functions by biotechs and pharma companies expands the addressable market.

Risk Factors

Revenue is vulnerable to downturns in biopharma R&D spending and client budgets.
Intense competition from large, full-service CROs and other niche players could pressure pricing and market share.
The business carries significant regulatory and reputational risk, as any data quality or compliance failure could be catastrophic.

Competitive Landscape

Veloxity competes in the fragmented bioanalytical CRO market against global giants (e.g., Labcorp, IQVIA, Charles River) and many smaller, specialized labs. Its primary differentiation is its branded focus on ultra-fast turnaround times, supported by proprietary workflow automation. It also competes by offering deep expertise in high-demand areas like peptide analysis, where specialized knowledge creates a competitive moat.

More companies in Diagnostics & Precision Medicine →More companies in United States →